These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 18578034)

  • 1. Changes are recommended in use of nelfinavir.
    Wilcox RD
    HIV Clin; 2008; 20(1):1, 4. PubMed ID: 18578034
    [No Abstract]   [Full Text] [Related]  

  • 2. The Viracept (nelfinavir)--ethyl methanesulfonate case: a threshold risk assessment for human exposure to a genotoxic drug contamination?
    Lutz WK
    Toxicol Lett; 2009 Nov; 190(3):239-42. PubMed ID: 19695319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What happened: the chemistry side of the incident with EMS contamination in Viracept tablets.
    Gerber C; Toelle HG
    Toxicol Lett; 2009 Nov; 190(3):248-53. PubMed ID: 19857795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
    Müller L; Gocke E; Lavé T; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMS in Viracept--the course of events in 2007 and 2008 from the non-clinical safety point of view.
    Müller L; Singer T
    Toxicol Lett; 2009 Nov; 190(3):243-7. PubMed ID: 19857794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Viracept-EMS case: impact and outlook.
    Walker VE; Casciano DA; Tweats DJ
    Toxicol Lett; 2009 Nov; 190(3):333-9. PubMed ID: 19866516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recall of AIDS drug hits world's poorest patients.
    AIDS Read; 2007 Sep; 17(9):439. PubMed ID: 17902224
    [No Abstract]   [Full Text] [Related]  

  • 8. In-utero exposure to nelfinavir-ethyl methyl sulfone.
    Hleyhel M; Goujon S; Sibiude J; Blanche S; Warszawski J;
    AIDS; 2016 Nov; 30(17):2729-2730. PubMed ID: 27662548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report from the 4th International Workshop on Clinical Pharmacology of HIV Therapy. New formulation of nelfinavir on the way.
    TreatmentUpdate; 2003; 15(3):6. PubMed ID: 17216848
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug design: new inhibitors for HIV-1 protease based on Nelfinavir as lead.
    Perez MA; Fernandes PA; Ramos MJ
    J Mol Graph Model; 2007 Oct; 26(3):634-42. PubMed ID: 17459746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EMS in Viracept--initial ('traditional') assessment of risk to patients based on linear dose response relations.
    Gocke E; Müller L; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):266-70. PubMed ID: 19439165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nelfinavir, a new protease inhibitor: early clinical results.
    Powderly WG; Tebas P
    AIDS; 1999 Sep; 13 Suppl 1():S41-8. PubMed ID: 10546784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caution regarding nelfinavir use in children and pregnant women.
    AIDS Clin Care; 2007 Nov; 19(11):96. PubMed ID: 18399001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cheap AIDS drugs for developing countries.
    de Boer J
    Trends Cell Biol; 2001 Nov; 11(11):450. PubMed ID: 11684423
    [No Abstract]   [Full Text] [Related]  

  • 15. Nelfinavir (Viracept).
    Res Initiat Treat Action; 2000 Mar; 6(1):30-1. PubMed ID: 11708185
    [No Abstract]   [Full Text] [Related]  

  • 16. In vivo and in vitro characterization of ethyl methanesulfonate pharmacokinetics in animals and in human.
    Lavé T; Birnböck H; Götschi A; Ramp T; Pähler A
    Toxicol Lett; 2009 Nov; 190(3):303-9. PubMed ID: 19695315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nelfinavir safe and effective in HIV/HCV patients.
    AIDS Patient Care STDS; 2003 Nov; 17(11):602-3. PubMed ID: 14750219
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term response for nelfinavir.
    AIDS Patient Care STDS; 2001 Sep; 15(9):495. PubMed ID: 11587636
    [No Abstract]   [Full Text] [Related]  

  • 19. Two possible pathways for acquisition of mutations related to nelfinavir resistance.
    Sugiura W; Oishi T; Okano A; Matsuda M; Abumi H; Yamada K; Koike M; Taki M; Ishikawa M; Miura T; Fukutake K; Gouchi K; Ajisawa A; Iwamoto A; Hanabusa H; Mimaya J; Takamatsu J; Takata N; Kakishita E; Higasa S; Kashiwagi S; Shirahata A; Nagai Y
    Jpn J Infect Dis; 1999 Aug; 52(4):175-6. PubMed ID: 10592904
    [No Abstract]   [Full Text] [Related]  

  • 20. Nelfinavir tolerated in HCV patients.
    AIDS Patient Care STDS; 2002 Dec; 16(12):617. PubMed ID: 12881882
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.